Abstract
We investigated the hypothesis that one of the actions of adenosine 3',5'- cyclic monophosphate (cAMP) to attenuate agonist-induced increase in microvessel permeability is to reduce the initial increase in endothelial cell cytoplasmic Ca2+ concentration ([Ca2+](i)). ATP (10 μM) was used to increase hydraulic conductivity (L(p)) and [Ca2+](i) in venular microvessel in frog mesentery. The cAMP analogue, 8-bromo-cAMP (8-BrcAMP, 2 mM) significantly attenuated the initial increase in L(p) (from a peak increase of 7.1 ± 2.4 times control with ATP alone to 1.2 ± 0.34 times control with ATP and cAMP). In contrast, cAMP did not significantly change the magnitude or time course of the biphasic increase in [Ca2+](i), which increased from 54 ± 5 nM to a peak of 187 ± 48 nM with ATP alone, and from 55 ± 8 nM to 190 ± 28 nM with ATP and cAMP. Thus the action of cAMP to attenuate microvessel permeability increase in the presence of ATP does not involve modification of the initial Ca2+ transient in endothelial cells. Our results enable alternative hypotheses, such as the suggestion that cAMP might modulate a Ca2+-calmodulin-dependent actin-myosin cascade, to be investigated without the added complications of having to account for the modulation of initial changes in [Ca2+](i). Our data also demonstrate, for the first time in the endothelial cells of intact microvessels, that an increase in [Ca2+](i) is not always associated with an increase in microvessel permeability.
Original language | English (US) |
---|---|
Pages (from-to) | H1019-H1023 |
Journal | American Journal of Physiology - Heart and Circulatory Physiology |
Volume | 265 |
Issue number | 3 34-3 |
DOIs | |
State | Published - 1993 |
All Science Journal Classification (ASJC) codes
- Physiology
- Cardiology and Cardiovascular Medicine
- Physiology (medical)